Publikationen in Zusammenarbeit mit Forschern von Goethe University Frankfurt (10)

2019

  1. Deep Learning Reveals Cancer Metastasis and Therapeutic Antibody Targeting in the Entire Body

    Cell, Vol. 179, Núm. 7, pp. 1661-1676.e19

2018

  1. Corrigendum to “European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)” (Redox Biol. (2017) 13 (94–162)(S2213231717303373)(10.1016/j.redox.2017.05.007))

    Redox Biology

  2. PHD3 controls lung cancer metastasis and resistance to EGFR inhibitors through TGFa

    Cancer Research, Vol. 78, Núm. 7, pp. 1805-1819

2017

  1. BMP-9 interferes with liver regeneration and promotes liver fibrosis

    Gut, Vol. 66, Núm. 5, pp. 939-954

  2. European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)

    Redox Biology, Vol. 13, pp. 94-162

2016

  1. EphrinB2 repression through ZEB2 mediates tumour invasion and anti-angiogenic resistance

    Nature Communications, Vol. 7

2014

  1. Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFR

    Nature Communications, Vol. 5

2013

  1. Basement Membrane-Rich Organoids with Functional Human Blood Vessels Are Permissive Niches for Human Breast Cancer Metastasis

    PLoS ONE, Vol. 8, Núm. 8

  2. Generation and characterization of monospecific and bispecific hexavalent trimerbodies

    mAbs, Vol. 5, Núm. 1, pp. 70-79

  3. Proteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodies

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, Núm. 34, pp. 13791-13796